Pfizer plans no-profit drugs in poorer nations

Pfizer will make patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said in Davos on Wednesday. Julian Satterthwaite reports.